Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1989 | 12-1988 | 09-1988 | 06-1988 | 03-1988 | |
| Sales | 0 | 488 | 573 | -397 | 314 |
| Cost of Goods | 0 | 421 | 465 | -1,637 | 630 |
| Gross Profit | 0 | 67 | 107 | 4,137 | -316 |
| Operating Expenses | 301 | 1,113 | 1,166 | -1,501 | 1,470 |
| Operating Income | -301 | -625 | -593 | 2,104 | -1,156 |
| Interest Expense | 2 | 11 | 12 | -293 | 96 |
| Other Income | 111 | 38 | 54 | 3,308 | 120 |
| Pre-tax Income | -192 | -597 | -551 | 5,704 | -1,132 |
| Income Tax | 11 | 11 | 14 | 483 | 0 |
| Net Income Continuous | -203 | -609 | -565 | 5,148 | -1,123 |
| Net Income Discontinuous | 0 | 0 | 0 | -2,273 | 0 |
| Net Income | $-203 | $-609 | $-565 | $2,875 | $-1,123 |
| EPS Basic Total Ops | N/A | N/A | N/A | 0.62 | N/A |
| EPS Basic Continuous Ops | N/A | N/A | N/A | 1.11 | N/A |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.49 | N/A |
| EPS Diluted Total Ops | N/A | N/A | N/A | 0.62 | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | 1.11 | N/A |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.49 | N/A |
| EBITDA(a) | $-301 | $-625 | $-593 | $2,104 | $-1,156 |